Presentations

BioCardia Corporate Presentation
The Science of CardiAMP Cell Therapy
Meeting on the Mesa "Successful Strategies in the Design and Delivery of a Cell/Gene Therapy Clinical Development Program"

Events

September 2020

Date and Time: September 1, 2020 at 10:20 am (Eastern Time)
Event: LD Micro 500 Conference
Webcast Link: https://www.webcaster4.com/Webcast/Page/2019/36064

August 2020

Date and Time: August 13, 2020 at 8:30 am (Eastern Time)
Event: BioCardia Mid-Year Conference Call
Participant Dial-In (Toll Free): 1-877-270-2148
Participant International Dial-In: 1-412-902-6510
Dial-in 10 minutes prior to start and request to join BioCardia Call
To listen to the broadcast, click here

March 2020

Date and Time: March 31, 2020 at 1:15 PT (4:15 ET)
Event: CardiAMP Heart Failure Trial Principal Investigators Call
Participant Dial-In (Toll Free): 1-877-270-2148
Participant International Dial-In: 1-412-902-6510
Request to join BioCardia Call
To listen to the broadcast, click here

October 2019

Date: October 28-29, 2019
Location: Jupiter, FL
Event: Dawson James Securities 5th Annual Small Cap Growth Conference
To register and view a LIVE broadcast, click here



News

08 Feb

Cell & Gene

Inside BioCardia's CardiAMP Cell Therapy
Read More
15 Sep

BioTuesdays

BioCardia developing autologous and allogenic cardiovascular cell therapies
Read More
03 Aug

Pharmaceutical Technology

BioCardia’s novel CardiAMP stem cell therapy closer to approval in heart failure
Read More
28 Jul

The Big Biz show

The Big Biz Show interviews BioCardia CEO, Peter Altman
Read More
10 Jan

HealthCare Weekly

5 Innovations That Will Change the Treatment of Heart Disease
Read More
28 Oct

Cardiology Today

Ongoing trial assessing novel assay to determine response to cardiac regenerative therapy
Read More

press releases

23 Feb
2021 BioCardia Signs Agreement with Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates
17 Feb
2021 BioCardia Announces Clinical Leadership Changes
02 Feb
2021 BioCardia Update on Cell Therapy Product Development and 2021
11 Jan
2021 Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia’s Board of Directors
30 Dec
2020 BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
17 Dec
2020 BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed
Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.
CLINICAL TRIALS